EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSCGOG00000018013
Gene Symbol: KIF5B
3 Cross references
245 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSCGOG00000012075
Gene Symbol: LTA4H
3 Cross references
205 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSCGOG00000024597
Gene Symbol: LOC115022307
3 Cross references
167 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSCGOG00000020091
Gene Symbol: LOC115023695
3 Cross references
143 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSCGOG00000009213
Gene Symbol: LOC115024528
3 Cross references
201 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSCGOG00000009652
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSCGOG00000007150
Gene Symbol: LOC115008139
3 Cross references
208 Possible Orthologues:

Lysyl Oxidase Homolog 2b-Like

Ensembl ID : ENSCGOG00000004464
Gene Symbol: LOC115013357
3 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2-Like

Ensembl ID : ENSCGOG00000012649
Gene Symbol: LOC115018832
2 Cross references
197 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSCGOG00000008053
Gene Symbol: MIF
3 Cross references
235 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSCGOG00000000720
Gene Symbol: MST1R
2 Cross references
194 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSCGOG00000001889
Gene Symbol: LOC115007953
2 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).